IOVA Chart
See on advanced chart >
About
Iovance Biotherapeutics, Inc. is an emerging biotechnology company focused on developing and commercializing adoptive cell therapy (ACT) using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of metastatic melanoma and other solid cancers....
Read More
- HighlightA late-stage biotech company that develops novel T cell-based cancer immunotherapies
- ExchangeNASDAQ
- Listing Date02/26/2015
- Established Date09/17/2007
- Full-time Employees557
- Address825 Industrial Road Suite 400 San Carlos California 94070
- Tel1-650-2607120
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology